Stability of a 1 beta-methylcarbapenem antibiotic, meropenem (SM-7338) in aqueous solution. 1995

Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
Research Center Sumitomo Pharmaceuticals Co., Ltd., Osaka, Japan.

The stability and the degradation products of 1 beta-methylcarbapenem, meropenem in aqueous solution were investigated. In pH 4-8 dilute solution, pseudo-first-order degradation was observed, and good stability of meropenem in aqueous solution was demonstrated by the effect of 1 beta-methyl group against hydrolysis of beta-lactam ring. As degradation products, the beta-lactam hydrolyzed product and the dimer product resulting from intermolecular aminolysis of beta-lactam ring by the amine of the second molecule were described.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D000077731 Meropenem A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid,Merrem,Penem,Ronem,SM 7338,SM-7338,SM7338
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D012996 Solutions The homogeneous mixtures formed by the mixing of a solid, liquid, or gaseous substance (solute) with a liquid (the solvent), from which the dissolved substances can be recovered by physical processes. (From Grant & Hackh's Chemical Dictionary, 5th ed) Solution
D013845 Thienamycins Beta-lactam antibiotics that differ from PENICILLINS in having the thiazolidine sulfur atom replaced by carbon, the sulfur then becoming the first atom in the side chain. They are unstable chemically, but have a very broad antibacterial spectrum. Thienamycin and its more stable derivatives are proposed for use in combinations with enzyme inhibitors. Antibiotics, Thienamycin,Thienamycin Antibiotics
D014867 Water A clear, odorless, tasteless liquid that is essential for most animal and plant life and is an excellent solvent for many substances. The chemical formula is hydrogen oxide (H2O). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Hydrogen Oxide

Related Publications

Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
July 1989, Antimicrobial agents and chemotherapy,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
February 1989, Antimicrobial agents and chemotherapy,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
May 1990, The Journal of antibiotics,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
December 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
December 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
October 1989, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
January 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
January 1990, Diagnostic microbiology and infectious disease,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
January 2022, AAPS open,
Y Takeuchi, and M Sunagawa, and Y Isobe, and Y Hamazume, and T Noguchi
April 1991, Pharmaceutical research,
Copied contents to your clipboard!